NEUROGENECES, INC. — Department of Defense STTR Phase II: AF21B-TCSO1
NEUROGENECES, INC. — STTR Phase II award from Department of Defense.
Phase II STTR prototype / development signal
- Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $749,986 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Topic code AF21B-TCSO1 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.
- Amount
- $749,986
- Agency
- Department of Defense · Air Force
- Program / Phase
- STTR · Phase II
- Topic
- AF21B-TCSO1
- Solicitation
- X21.B
- NAICS
- —
- Place of performance
- NM
- Period
- 2022-07-27 → 2023-11-27
Description
Air Force Special Operations Command (AFSOC) and Air Force Education and Training Command (AETC) have a National Defense-related mission requirement to sustain the overall health and well-being of Airmen and their families. Through the Preservation of the